Why the study?
Detection of diffuse interstitial fibrosis remains challenging with late gadolinium enhancement, necessitating the exploration of alternative CMR techniques like T1 mapping across cardiac diseases.
Does T1 mapping with CMR improve the detection of diffuse and focal myocardial fibrosis compared to LGE in patients with cardiac disease?
Does T1 mapping with CMR improve the detection of diffuse and focal myocardial fibrosis compared to LGE in patients with cardiac disease?
Answers are grounded in this paper and cite their sources.
T1 mapping with CMR is a promising technique for characterizing myocardial tissue, particularly for detecting diffuse interstitial fibrosis that LGE may miss.
Purpose of the Review This paper delves into the emerging realm of T1 mapping, exploring recent innovations and their relevance across several cardiac diseases. Recent Findings T1 mapping with cardiovascular magnetic resonance (CMR) imaging has emerged as a valuable tool for cardiac disease evaluation, offering diagnostic, therapeutic, and prognostic insights. Tissue characterization using parametric mapping methods holds the promise of identifying and quantifying both focal and diffuse changes in myocardial structure, which cannot be adequately assessed through late gadolinium enhancement (LGE). Summary CMR imaging, particularly LGE, has enhanced cardiac tissue characterization. However, the detection of diffuse interstitial fibrosis remains challenging, necessitating the exploration of alternative techniques. T1 mapping could probably represent a game changer in the evaluation of diffuse and focal fibrosis in multiple cardiovascular conditions.
No takes yet. Share an insight, caveat, or question.
Ascione et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: